Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
2210.00Today’s High
2260.0052W low
1246.8052W High
2354.00Open Price
2225.00Prev. Close
2124.3000Volume
91034.00Value
203369956.00Fundamentals
Market Cap Cr
28129.60
Price to Earnings
34.50
Price to Book Value
7.90
Dividend Yield
2.30
PE to Growth
0.90
Op Revenue TTM Cr
4208.71
Net Profit TTM Cr
816.17
Cash From Operating Activity Cr
0.00
Return on Equity %
22.87
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
02 May, 2024
52.4
Week
47.1
Month
56.4
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
2234.67
PIVOT
First Resistance
2259.33
Second Resistance
2284.67
Third Resistance
2309.33
First Support
2209.33
Second Support
2184.67
Third Support
2159.33
Relative Strength Index
63.37
Money Flow Index
74.77
MACD
13.33
MACD Signal
0.83
Average True Range
67.46
Average Directional Index
27.24
Rate of Change (21)
0.14
Rate of Change (125)
27.34
Commodity Channel Index
100.1
Williams %R
-22.5
BETA
1 Month
-0.12
3 Month
0.03
1 Year
-0.04
3 Year
0.01
PRICE CHANGE ANALYSIS
↑ 4.7%
1 Week
Low
High
2120
2286.95
↓ -0.21%
1 Month
Low
High
2051.6
2311.95
↑ 2.42%
3 Months
Low
High
1998.35
2319.75
↑ 22.24%
6 Months
Low
High
1782.3
2353.95
↑ 70.2%
1 Year
Low
High
1246.75
2353.95
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 959.75 | 1099.02 | 997.34 | 1046.04 | 885.61 | 905.40 | 915.60 | 885.71 | 794.05 | 836.48 | 876.12 | |
| Operating Expenses Qtr | 698.92 | 758.11 | 671.53 | 737.68 | 704.33 | 715.48 | 676.50 | 663.98 | 578.48 | 570.71 | 590.86 | |
| Operating Profit Qtr | 227.15 | 327.18 | 273.65 | 276.90 | 144.53 | 159.41 | 160.73 | 186.31 | 187.15 | 237.87 | 232.85 | |
| EBIDT Qtr Cr | 260.83 | 340.91 | 325.81 | 308.36 | 181.28 | 189.92 | 239.10 | 221.73 | 215.57 | 265.77 | 285.26 | |
| Depreciation Qtr | 33.47 | 33.41 | 33.04 | 32.24 | 32.11 | 32.29 | 31.80 | 30.75 | 30.09 | 30.71 | 30.40 | |
| Net Profit Qtr | 162.69 | 220.15 | 212.36 | 212.04 | 117.21 | 123.96 | 167.18 | 150.37 | 134.84 | 194.71 | 196.85 | |
| Basic EPS Qtr | 12.92 | 17.48 | 16.87 | 16.84 | 9.15 | 9.67 | 13.05 | 11.74 | 15.79 | 22.50 | 22.75 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 4087.60 | 3544.02 | 3280.37 | 2822.16 | 2380.62 | |
| Operating Expenses Annual Cr | 2851.69 | 2711.99 | 2249.75 | 1801.68 | 1663.64 | |
| Operating Profit Annual | 1119.43 | 699.28 | 890.89 | 916.91 | 532.78 | |
| Operating Profit Margin Annual % | 27.39 | 19.73 | 27.16 | 32.49 | 22.38 | |
| Total Expenses Annual Cr | 2990.65 | 2844.17 | 2379.83 | 1920.07 | 1764.03 | |
| EBIDT Annual Cr | 1235.91 | 832.03 | 1030.62 | 1020.48 | 716.98 | |
| EBIDT Annual margin % | 30.24 | 23.48 | 31.42 | 36.16 | 30.12 | |
| Depreciation | 132.16 | 126.95 | 120.96 | 111.49 | 91.29 | |
| PAT Before ExtraOrdinary Items Annual Cr | 807.24 | 558.72 | 719.86 | 675.64 | 441.13 | |
| Net Profit Annual | 807.24 | 558.72 | 719.86 | 675.64 | 441.13 | |
| Basic EPS Annual | 64.11 | 43.61 | 83.28 | 77.59 | 50.55 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3413.57 | 3246.45 | 3169.18 | 2884.98 | 2461.30 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 174.17 | 150.50 | 141.61 | 130.99 | 112.91 | |
| Total Current Liabilities Annual Cr | 629.70 | 907.84 | 469.70 | 516.09 | 474.94 | |
| Total Capital Plus Liabilities Annual Cr | 4217.44 | 4304.79 | 3780.49 | 3532.06 | 3049.15 | |
| Fixed Assets Annual | 1721.34 | 1693.48 | 1645.18 | 1626.98 | 1580.38 | |
| Total Non Current Assets Annual | 1775.77 | 1753.60 | 1723.48 | 1695.85 | 1634.07 | |
| Total Current Assets Annual | 2441.67 | 2551.19 | 2057.01 | 1836.21 | 1415.08 | |
| Total Assets Annual | 4217.44 | 4304.79 | 3780.49 | 3532.06 | 3049.15 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 91.52 | 76.44 | 168.98 | 182.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 0.00 | 736.29 | 542.34 | 466.99 | 300.88 | |
| Cash from Investing Activity Annual | 0.00 | -501.31 | -66.04 | -162.68 | -115.91 | |
| Cash from Financing Annual Activity | 0.00 | -105.12 | -457.30 | -268.90 | -134.00 | |
| Net Cash Flow Annual | - | 129.86 | 19.00 | 35.41 | 50.97 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 270.17 | 256.94 | 369.15 | 331.80 | 280.65 | |
| ROE Annual % | 23.64 | 17.21 | 22.71 | 23.41 | 17.92 | |
| ROCE Annual % | 30.76 | 20.75 | 27.47 | 30.13 | 24.30 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 31.12 | 24.39 | 32.81 | 37.53 | 32.64 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1089.58 | 1118.74 | 1049.77 | 1052.79 | 918.67 | 1006.70 | 978.45 | 983.69 | 899.77 | 861.94 | 914.34 | |
| Operating Expenses Qtr | 775.76 | 791.08 | 737.78 | 749.72 | 732.47 | 802.22 | 741.76 | 729.17 | 663.60 | 598.33 | 621.98 | |
| Operating Profit Qtr | 278.32 | 314.07 | 290.66 | 271.32 | 149.37 | 169.55 | 196.34 | 221.76 | 206.69 | 239.58 | 262.82 | |
| EBIDT Qtr Cr | 313.82 | 327.66 | 311.99 | 303.07 | 186.20 | 204.48 | 236.69 | 254.52 | 236.17 | 263.61 | 292.36 | |
| Depreciation Qtr | 34.25 | 34.26 | 33.71 | 33.18 | 33.02 | 33.30 | 32.70 | 31.78 | 31.16 | 31.72 | 31.54 | |
| Net Profit Qtr | 202.72 | 210.03 | 195.30 | 208.12 | 122.25 | 134.51 | 156.60 | 174.62 | 151.21 | 191.78 | 195.94 | |
| Basic EPS Qtr | 16.10 | 16.68 | 15.51 | 16.53 | 9.54 | 10.50 | 12.22 | 13.63 | 17.70 | 22.16 | 22.64 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 4293.31 | 3841.28 | 3456.67 | 2915.67 | 2680.06 | |
| Operating Expenses Annual Cr | 3036.77 | 2959.39 | 2411.69 | 1891.13 | 1904.54 | |
| Operating Profit Annual | 1171.94 | 783.25 | 929.30 | 998.56 | 683.33 | |
| Operating Profit Margin Annual % | 27.30 | 20.39 | 26.88 | 34.25 | 25.50 | |
| Total Expenses Annual Cr | 3179.38 | 3096.03 | 2547.19 | 2015.49 | 2012.17 | |
| EBIDT Annual Cr | 1256.54 | 881.89 | 1044.98 | 1024.54 | 775.52 | |
| EBIDT Annual margin % | 29.27 | 22.96 | 30.23 | 35.14 | 28.94 | |
| Depreciation | 135.40 | 130.80 | 125.30 | 116.09 | 95.72 | |
| PAT Before ExtraOrdinary Items Annual Cr | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 | |
| Net Profit Annual | 816.17 | 587.98 | 712.68 | 653.87 | 467.70 | |
| Basic EPS Annual | 64.82 | 45.89 | 82.45 | 75.09 | 53.60 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3567.36 | 3387.99 | 3264.34 | 2995.63 | 2598.87 | |
| Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non Current Liabilities Annual Cr | 175.27 | 151.75 | 143.85 | 134.46 | 113.65 | |
| Total Current Liabilities Annual Cr | 895.76 | 1139.28 | 647.39 | 648.63 | 606.17 | |
| Total Capital Plus Liabilities Annual Cr | 4638.39 | 4679.02 | 4055.58 | 3778.72 | 3318.69 | |
| Fixed Assets Annual | 1735.64 | 1705.91 | 1664.85 | 1649.30 | 1604.00 | |
| Total Non Current Assets Annual | 1907.47 | 1845.02 | 1791.12 | 1751.13 | 1676.98 | |
| Total Current Assets Annual | 2730.92 | 2834.00 | 2264.46 | 2027.59 | 1641.71 | |
| Total Assets Annual | 4638.39 | 4679.02 | 4055.58 | 3778.72 | 3318.69 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 91.52 | 76.44 | 168.98 | 182.41 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 0.00 | 791.78 | 562.04 | 576.31 | 456.77 | |
| Cash from Investing Activity Annual | 0.00 | -559.60 | -74.10 | -282.39 | -224.41 | |
| Cash from Financing Annual Activity | 0.00 | -107.87 | -460.04 | -318.29 | -128.63 | |
| Net Cash Flow Annual | - | 124.31 | 27.90 | -24.37 | 103.73 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 282.34 | 268.14 | 380.24 | 344.52 | 296.34 | |
| ROE Annual % | 22.87 | 17.35 | 21.83 | 21.82 | 17.99 | |
| ROCE Annual % | 29.95 | 21.21 | 26.98 | 29.02 | 25.06 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | |
| EBDIT Annual Margin % | 29.85 | 23.56 | 31.27 | 35.45 | 29.96 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Kotak Small Cap Fund | 1.24 | 74518109 | - | - |
| Hdfc Large And Mid Cap Fund | 1.04 | 74518110 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Rajesh M Agrawal, trustee Rajesh Agrawal Trust | 14.48 | 74518095 | 0 | 0 |
| Yogesh M Agrawal, trustee Yogesh Agrawal Trust | 14.48 | 74518096 | 0 | 0 |
| Ravi P Agrawal, trustee Ravi Agrawal Trust | 13.01 | 74518097 | 32.85 | 0 |
| Aayush M Agrawal, trustee Aayush Agrawal Trust | 11.31 | 74518098 | 33.98 | 0 |
| Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal | 2.68 | 74518099 | 0 | 0 |
| Gabs Investments Pvt Ltd | 10 | 74518104 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| Uti Flexi Cap Fund | 3.08 | 74518107 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | 2.99 | 74518108 |
| Kotak Small Cap Fund | 1.24 | 74518109 |
| Hdfc Large And Mid Cap Fund | 1.04 | 74518110 |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | 1.65 | 74518112 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Feb 08, 2024 | 26 | INTERIM | Feb 08, 2024 | Equity Share |
| Aug 04, 2023 | 10 | INTERIM | Aug 04, 2023 | Equity Share |
| Aug 04, 2023 | 15 | SPECIAL | Aug 04, 2023 | Equity Share |
| Nov 11, 2022 | 7 | INTERIM | Nov 14, 2022 | Equity Share |
| Nov 09, 2021 | 9.5 | INTERIM | Nov 10, 2021 | Equity Share |
| Nov 12, 2020 | 9.5 | INTERIM | Nov 13, 2020 | Equity Share |
| Nov 15, 2019 | 13 | INTERIM | Nov 18, 2019 | Equity Share |
| Nov 09, 2018 | 9 | INTERIM | Nov 12, 2018 | Equity Share |
| Mar 23, 2017 | 7 | INTERIM | Mar 25, 2017 | Equity Share |
| Nov 07, 2016 | 6 | INTERIM | Nov 08, 2016 | Equity Share |
| Mar 17, 2016 | 8 | INTERIM | Mar 19, 2016 | Equity Share |
| Jun 25, 2015 | 6 | FINAL | - | Equity Share |
| Jul 24, 2014 | 10 | FINAL | - | Equity Share |
| Jul 18, 2013 | 6.25 | FINAL | - | Equity Share |
| Jun 28, 2012 | 7.5 | FINAL | - | Equity Share |
| Jun 23, 2011 | 5 | FINAL | - | Equity Share |
| Jun 29, 2010 | 3.5 | FINAL | - | Equity Share |
| Jun 30, 2009 | 2.5 | FINAL | - | Equity Share |
| Jun 27, 2008 | 2.5 | FINAL | - | Equity Share |
| Sep 19, 2007 | 2 | FINAL | - | Equity Share |
| Sep 18, 2006 | 1.5 | FINAL | - | Equity Share |
| Dec 17, 2002 | - | FINAL | - | Equity Share |
| Sep 05, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| Mar 20, 2015 | 5:2 | - |
| Aug 09, 2012 | 10:5 | 2012-08-10 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results & Buy Back of Shares | - |
| Jan 31, 2024 | Quarterly Results & 2nd Interim Dividend | - |
| Oct 31, 2023 | Quarterly Results | - |
| Jul 27, 2023 | Quarterly Results | - |
| May 05, 2023 | Audited Results | - |
| Mar 10, 2023 | Buy Back of shares | - |
| Feb 01, 2023 | Quarterly Results | - |
| Nov 03, 2022 | Quarterly Results & Interim Dividend | - |
| Jul 28, 2022 | Quarterly Results | - |
| May 10, 2022 | Audited Results & Bonus issue | - |
| Jan 31, 2022 | Quarterly Results | - |
| Dec 28, 2021 | Buy Back of Shares | - |
| Oct 29, 2021 | Quarterly Results & Interim Dividend | - |
| Jul 29, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results | - |
| Feb 02, 2021 | Quarterly Results | - |
| Nov 03, 2020 | Quarterly Results & Interim Dividend | Buy Back of Shares |
| Jul 30, 2020 | Quarterly Results | - |
| May 20, 2020 | Audited Results | - |
| Feb 05, 2020 | Quarterly Results | - |
| Nov 05, 2019 | Quarterly Results & Interim Dividend | - |
| Jul 31, 2019 | Quarterly Results | - |
| Apr 30, 2019 | Audited Results | - |
| Jan 30, 2019 | Quarterly Results & Buy Back of Shares | - |
| Oct 31, 2018 | Quarterly Results & Interim Dividend | - |
| Jul 31, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results | - |
| Jan 25, 2018 | Quarterly Results | - |
| Oct 31, 2017 | Quarterly Results | - |
| Aug 09, 2017 | Quarterly Results | - |
| May 03, 2017 | Audited Results | - |
| Mar 18, 2017 | Second Interim Dividend | - |
| Jan 24, 2017 | Quarterly Results | - |
| Oct 26, 2016 | Quarterly Results & Interim Dividend | - |
| Jul 26, 2016 | Quarterly Results | - |
| Apr 29, 2016 | Audited Results & Final Dividend | - |
| Mar 09, 2016 | Interim Dividend | - |
| Feb 01, 2016 | Quarterly Results | - |
| Oct 30, 2015 | Quarterly Results | - |
| Aug 13, 2015 | Quarterly Results | - |
| May 08, 2015 | Audited Results & Dividend | - |
| Jan 28, 2015 | Quarterly Results | - |
| Oct 30, 2014 | Quarterly Results | - |
| Aug 05, 2014 | Quarterly Results | - |
| Jun 13, 2014 | Appointments of Directors | To considering appointment of two Additional Directors of the company. |
| May 05, 2014 | Audited Results & Dividend | - |
| Jan 27, 2014 | Quarterly Results | - |
| Oct 28, 2013 | Quarterly Results | - |
| Jul 29, 2013 | Quarterly Results & Bonus issue | To consider Bonus issue of shares. |
| Apr 30, 2013 | Audited Results & Dividend | - |
| Jan 23, 2013 | Quarterly Results | - |
| Oct 25, 2012 | Quarterly Results | - |
| Jul 19, 2012 | Quarterly Results | - |
| Apr 26, 2012 | Audited Results, Dividend & Stock split | The Board the recommended Dividend @ Rs. 7.50 per Equity Share of the face value of Rs. 10/- each & approved sub-division of NV of Equity Shares of the Company from Rs. 10/- each to NV of Rs. 5/- each |
| Jan 24, 2012 | Quarterly Results | - |
| Oct 24, 2011 | Quarterly Results | - |
| Jul 28, 2011 | Quarterly Results | - |
| Apr 30, 2011 | Audited Results & Dividend | - |
| Jan 20, 2011 | Quarterly Results | - |
| Oct 22, 2010 | Quarterly Results | - |
| Jul 30, 2010 | Quarterly Results | - |
| May 06, 2010 | Audited Results & Dividend | - |
| Jan 29, 2010 | Quarterly Results | - |
| Oct 29, 2009 | Buy Back of Shares | The Board has approved buy back of Co's Shares through stock exchange for an amount of Rs. 11.36 crs. at a price not exceeding Rs. 101 per shares, subject to necessary applicable regulatory approvals. |
| Jul 30, 2009 | Quarterly Results | - |
| May 15, 2009 | Audited Results & Dividend | - |
| Jan 29, 2009 | Quarterly Results | - |
| Oct 23, 2008 | Quarterly Results | - |
| Jul 30, 2008 | Quarterly Results | - |
| Apr 30, 2008 | Audited Results & Dividend | - |
| Jan 30, 2008 | Quarterly Results | - |
| Oct 30, 2007 | Quarterly Results | - |
| Jul 30, 2007 | Quarterly Results | - |
| Apr 27, 2007 | Audited Results & Dividend | - |
| Jan 30, 2007 | Quarterly Results | - |
| Oct 30, 2006 | Quarterly Results | - |
| Apr 28, 2006 | Accounts & Dividend | - |
| Jan 27, 2006 | Quarterly Results | - |
| Oct 28, 2005 | Quarterly Results | - |
| Jul 30, 2005 | Quarterly Results | - |
| Apr 30, 2005 | Accounts | - |
| Jan 18, 2005 | Quarterly Results | - |
| Oct 29, 2004 | Quarterly Results | - |
| Jul 30, 2004 | Quarterly Results | - |
| May 22, 2004 | Accounts | - |
| Jan 10, 2004 | Quarterly Results | - |
| Oct 21, 2003 | Quarterly Results | - |
| Jul 26, 2003 | Quarterly Results | - |
| Jun 28, 2003 | Accounts | - |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 30, 2002 | Quarterly Results | - |
| Jul 29, 2002 | Quarterly Results | - |
| May 30, 2002 | Accounts & Dividend | - |
| Jan 28, 2002 | Quarterly Results | - |
| Oct 30, 2001 | Half Yearly Results | - |
| Jul 30, 2001 | Dividend & Quarterly Results | - |
| May 12, 2001 | Accounts | - |
| Jan 21, 2001 | Quarterly Results | - |
| Oct 21, 2000 | Half Yearly Results | - |
| Jul 15, 2000 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Jun 22, 2022 | 1:2 | 2022-06-23 |
| Sep 17, 2013 | 1:2 | 2013-09-18 |
02 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, audio call recording of the earnings call held on 2nd May 2024 at 4.30 p.m. has been uploaded on the Company's website and can be accessed through the link: https://ajantapharma.com//images/EarningsAudio-Q4-FY2024.mp3
02 May 2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Ajanta Pharma Ltd.
Pharmaceuticals company Ajanta Pharma announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Revenue from operations at Rs 1,054 crore against Rs 882 crore; up 20%. EBITDA at Rs 278 crore against Rs 149 crore; up 86%; EBITDA at 26%. Profit after tax at Rs 203 crore against Rs 122 crore; up 66%; PAT at 19%. FY24 Financial Highlights: Revenue from operations at Rs 4,209 crore against Rs 3,743 crore; up 12%. EBITDA at Rs 1,172 crore against Rs 783 crore; up 50%; EBITDA at 28%. Profit after tax at Rs 816 crore against Rs 588 crore; up 39%; PAT at 19%. Cashflow from operations (CFO) was Rs 785 crore, EBITDA to CFO conversion of 67%. Free cashflow (FCF) was Rs 637 crore, FCF to PAT conversion of 78%. Result PDF
02 May 2024
Ajanta Pharma Q4 Results: Posts 66% Rise In Net Profit To Rs 203 Crore
Revenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.
02 May 2024
AJANTA PHARMA LTD. - 532331 - Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015, Pls Find Enclosed Details For: 1. Appointment Of Cost Auditors 2. Vacancy Of Cost Auditors 3. Re-Appointment Of Secretarial Auditors 4. Re-Appointment Of Tax Auditors
Pls find enclosed details towards: 1. Appointment of Cost Auditors 2. Vacancy of Cost Auditors 3. Re-appointment of Secretarial Auditors 4. Re-appointment of Tax Auditors
02 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of SEBI (LODR), we hereby inform that at the Board Meeting held today, the Board approved appointment of following persons as Additional Non-Executive Independent Director subject to approval of members: 1. Mr. David Rasquinha 2. Mrs. Medha Joshi 3. Mr. Rajesh Dalal 4. Mrs. Simi Thapar
02 May 2024
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
NRC in its meeting held today allotted 1000 shares. Pls find attached enclosure for more details.
02 May 2024
AJANTA PHARMA LTD. - 532331 - For Fixing Of Record Date In Relation To The Proposed Buyback Under Regulation 42 Of The SEBI (LODR) Regulations, 2015
Record Date fixed for the Buy Back is 30th May 2024. Pls find enclosed Record date Intimation for further details.
02 May 2024
AJANTA PHARMA LTD. - 532331 - Results-Financial Results For 03,31,2024
Outcome of Board Meeting
02 May 2024
AJANTA PHARMA LTD. - 532331 - Board Meeting Outcome for Outcome Of Board Meeting For Approving Audited Financial Results And Proposal Of Buy Back Pursuant To Reg 33 And 30 Of SEBI (LODR)
We hereby inform that at the Board meeting held on Thursday, 2nd May 2024, Board has inter-alia approved the following: 1. Audited (Consolidated & Standalone) Financial Results of the Company for the quarter and year ended 31st March 2024. 2. Proposal of Buy Back. PFA enclosed outcome of Board Meeting for more details.
26 Apr 2024
AJANTA PHARMA LTD. - 532331 - Update on board meeting
AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(b) of the Listing Regulations and in continuation to our intimation dated April 22, 2024 about meeting of the Board of Directors of the Company scheduled to be held on Thursday, May 2, 2024, we hereby inform that at the said meeting, the Board will also consider a proposal for buy-back of Equity Shares of the Company and other matters incidental and necessary thereto, in accordance with the applicable provisions of the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws.
